AN2 Therapeutics

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1800 El Camino Real Ste 100, Menlo Park,...

Phone Number

(650) 331-9090

Revenue

-

Stock Symbol

ANTX

Industry

Business Services Research & Development

About AN2 Therapeutics

AN2 Therapeutics is a clinical-stage biopharmaceutical company developing boron-based drug candidates for infectious disease, hematology, and oncology. The company uses its chemistry platform to discover and advance novel therapies through preclinical research, clinical trials, and pipeline development aimed at serious unmet medical needs globallyExplore more
AN2 Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ANTXShow more

AN2 Therapeutics Org Chart

Eric Easom, Co-Founder, President & Chief Executive Officer at AN2 Therapeutics
United States flag for contact location.

Co-Founder, President & Chief Executive Offic...

PhoneEmail
Josh Eizen, Chief Operating Officer & Chief Legal Officer at AN2 Therapeutics
United States flag for contact location.

Chief Operating Officer & Chief Legal Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
SM
United States flag for contact location.

Executive Director, Medical Writing & Regulat...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to AN2 Therapeutics

Compare insights from companies similar to AN2 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

AN2 Therapeutics

11-50
Public
$201M
2017
Eric Easom, Co-Founder, President & Chief Executive Officer at AN2 Therapeutics
Eric EasomCo-Founder, President & CEO
$15.5M
1-10
Private
-
1984
SS
Summer SmithClinical Data Associate
$5.6M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
2020
PH
Pearl HuangPresident & CEO
<$5M
1-10
Private
$39.6M
2013
JT
John TuckerPresident & CEO
<$5M
11-50
Public
$125.3M
2011
Mittie Doyle, Chief Medical Officer at Avalo Therapeutics
Mittie DoyleChief Medical Officer
11-50
Public
$40M
2017
Rudqvist Nilspetter, Senior Director, Research at MiNK Therapeutics
Rudqvist NilspetterSenior Director, Research
Illustration of an envelope

AN2 Therapeutics Tech Stack

A closer look at the technologies used by AN2 Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding AN2 Therapeutics

What is AN2 Therapeutics's stock symbol?
AN2 Therapeutics's stock symbol is ANTX
What is AN2 Therapeutics's official website?
AN2 Therapeutics's official website is www.an2therapeutics.com
What is AN2 Therapeutics's SIC code?
AN2 Therapeutics's SIC: 28,283
What is AN2 Therapeutics's NAICS code?
AN2 Therapeutics's NAICS: 32,325
How many employees does AN2 Therapeutics have?
AN2 Therapeutics has 11-50 employees
What industry does AN2 Therapeutics belong to?
AN2 Therapeutics is in the industry of: Business Services, Research & Development
What is AN2 Therapeutics competition?
AN2 Therapeutics top competitors include: Poniard Pharmaceuticals, Celestial Therapeutics, MiNK Therapeutics, XyloCor Therapeutics
What technology does AN2 Therapeutics use?
Some of the popular technologies that AN2 Therapeutics uses are: YouTube, TriNet, Microsoft 365, Vimeo
How do I contact AN2 Therapeutics?
AN2 Therapeutics contact info: Phone number: (650) 331-9090 Website: www.an2therapeutics.com
What does AN2 Therapeutics do?

AN2 Therapeutics is a clinical-stage biopharmaceutical company developing boron-based drug candidates for infectious disease, hematology, and oncology. The company uses its chemistry platform to discover and advance novel therapies through preclinical research, clinical trials, and pipeline development aimed at serious unmet medical needs globally... Read More

What are AN2 Therapeutics social media links?
AN2 Therapeutics Linkedin page
Who invested in AN2 Therapeutics?
AN2 Therapeutics has 12 investors including Mountain Group Partners, BioRock Ventures, Adjuvant Capital and Brii Biosciences.
Is AN2 Therapeutics a public company?
Yes, AN2 Therapeutics is a public company and is traded under the symbol ANTX
See more information about AN2 Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.